本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Atara Biotherapeutics

7.60
+0.700010.14%
盤後7.600.00000.00%18:35 EDT
成交量:5.67萬
成交額:42.18萬
市值:4,452.77萬
市盈率:-0.67
高:7.76
開:6.97
低:6.94
收:6.90
資料載入中...
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/05

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/07/17

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/17

重要事件披露

Form 8-K - Current report
2024/06/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/22

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities